The FDA authorized the latest mRNA boosters for children as young as 6 months in September despite its own researchers finding a "Safety signal" for post-vaccination seizures and convulsions in 2- to 5-year-old children, a demographic at near-zero risk from SARS-CoV-2 itself.
Pfizer didn't try to wave away vaccine adverse events in its Oct. 13 press release on updates to its 2023 guidance.
Krohnert told Just the News she didn't think Pfizer was being "More honest than the CDC," just that the former's language has "a more matter-of-fact tone instead of a persuasive one" because it's on a package insert, which still characterizes the risk as "Very low." The CDC did not respond to queries about the rigor of its evidence for higher risk from natural infection or even the relevance of the comparison, given the vaccination cannot fully prevent infection.
Health Canada told The Epoch Times that Pfizer violated its obligation to tell the regulator about a "Simian Virus 40 DNA sequence" in its mRNA vaccine that a genomics researcher stumbled across and the Canadian regulator has since independently confirmed.
DNA contamination is "Something that regulatory agencies around the world have specifically said is not possible with the mRNA vaccines," Spectator Australia reported last month.
The U.K.'s Medicine and Healthcare products Regulatory Agency tacitly admitted it authorized Pfizer's vaccine without data on mass-manufactured specimens as opposed to small clinical batches, according to a retired Ministry of Defence official.
It's not clear why the ruling didn't attract wider attention before Vaccine Safety Research Foundation founder and former Democratic Party megadonor Steve Kirsch touted it Saturday as "Breaking" news.
No comments:
Post a Comment